Sexual dysfunction associated with antidepressant drugs

Bibliographys

• BONIERBALE M, LANCON C, TIGNOL J: The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France. Curr. Med. Res. Opin. (2003) 19:114–124.
   PubMed Web of Science ®Google Scholar
• ATMACA M, KULOGLU M, TEZCAN E, BUYUKBAYRAM A: Switching to tianeptine in patients with antidepressant-induced sexual dysfunction. Hum. Psychopharmacol. (2003) 18:277–280.
   PubMed Web of Science ®Google Scholar
• GOODMAN RE: An assessment of clomipramine (Anafranil) in the treatment of premature ejaculation. J Int. Med. Res. (1980) 8\(Suppl. 3):53–59.
   Google Scholar
• KIM SC, SEO KK: Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo-controlled study. J. Urol. (1998) 159:425–427.
   PubMed Web of Science ®Google Scholar
• MURAT BASAR M, ATAN A, YILDIZ M, BAYKAM M, AYDOGANLI L: Comparison of sertraline to fluoxetine with regard to their efficacy and side effects in the treatment of premature ejaculation. Archiv. Esp. Urol. (1999) 52:1008–1011.
   PubMedGoogle Scholar
• MANASIA P, POMEROL J, RIBE N, GUTIERREZ DEL POZO R, ALCOVER GARCIA J: Comparison of the efficacy and safety of 90 mg versus 20 mg fluoxetine in the treatment of premature ejaculation. J Urol. (2003) 170:164–165.
   PubMed Web of Science ®Google Scholar
• MCMAHON CG, TOUMA K: Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo-controlled crossover studies./ Urol. (1999) 161:1826–1830.
   PubMed Web of Science ®Google Scholar
• ROWLAND DL, GOUVEIA BRAZAO CA, KOOS SLOB A: Effective daily treatment with clomipramine in men with premature ejaculation when 25 mg (as required) is ineffective. BJU Int. (2001) 87:357–360.
   PubMed Web of Science ®Google Scholar
• WALDINGER MD, HENGEVELD MW, ZWINDERMAN AH: Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomized, dose-response study. Br. J. Urol. (1997) 79:592–595.
   PubMedGoogle Scholar
• ATAN A, BASAR MM, AYDOGANLI L: Comparison of the efficacy of fluoxetine alone versus fluoxetine plus local lidocaine ointment in the treatment of premature ejaculation. Archiv. Esp. Urol. (2000) 53:856–858.
   PubMedGoogle Scholar
• SALONIA A, MAGA T, COLOMBO R et al.: A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. Urol. (2002) 168:2486–2489.
   Web of Science ®Google Scholar
• CHEN J, MABJEESH NJ, MATZKIN H, GREENSTEIN A: Efficacy of sildenafil as adjuvant therapy to selective serotonin re-uptake inhibitor in alleviating premature ejaculation. Urology (2003) 61:197–200.
   PubMed Web of Science ®Google Scholar
• McMAHON CG: Presented at EuropeanSociety for Sexual Medicine, Turkey 2003.
   Google Scholar
• YILMAZ U, TATLISEN A, TURAN H, ARMAN F, EKMEKCIOGLU 0: The effects of fluoxetine on several neurophysiological variables in patients with premature ejaculation. Clin. Polchiatry (1999) 161:107–111.
   Google Scholar
• ROWLAND DL, TAI WL, SLOB AK: An exploration of emotional response to erotic stimulation in men with premature ejaculation: effects of treatment with clomipramine. Arch. Sex. Behav. (2003) 32:145–153.
   PubMed Web of Science ®Google Scholar
• ATMACA M, KULOGLU M, TEZCAN E, SEMERCIOZ A: The efficacy of citaloprarn in the treatment of premature ejaculation: a placebo-controlled study. Int. J. Impot. Res. (2002) 14:502–505.
   PubMed Web of Science ®Google Scholar
• STRASSBERG DS, GOUVEIA BRAZAO CA, ROWLAND DL, TAN P, SLOB AK: Clomipramine in the treatment of rapid (premature) ejaculation. J. Sex Marital Ther. (1999) 25:89–101.
   PubMed Web of Science ®Google Scholar
• BIRI H, ISEN K, SINIK Z, ONARAN M, KUPELI B, BOZKIRLI I: Sertraline in the treatment of premature ejaculation: a double-blind placebo-controlled study. Int. Urol. Nephrol. (1998) 30:611–615.
   PubMedGoogle Scholar
• MCMAHON CG: Treatment of prematureejaculation with sertraline hydrochloride: a single-blind placebo-controlled crossover study. J. Urol. (1998) 159:1935–1938.
   PubMed Web of Science ®Google Scholar
• HAENSEL SM, KLEM TM, HOP WC, SLOB AK: Fluoxetine and premature ejaculation: a double-blind, crossover, placebo-controlled study. J. Clin. Psychopharmacol. (1998) 18:72–77.
   PubMed Web of Science ®Google Scholar
• KARA H, AYDIN S, YUCEL M, AGARGUN MY, ODABAS 0, YILMAZY: The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo-controlled study. J. Urol. (1996) 156:1631–1632.
   PubMed Web of Science ®Google Scholar
• HAENSEL SM, ROWLAND DL, KALLAN KT: Clomiprarnine and sexual function in men with premature ejaculation and controls]. Urol. (1996) 156:1310–1315.
   Web of Science ®Google Scholar
• WALDINGER MD, HENGEVELD MW, ZWINDERMAN AH: Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am. J Psychiatry (1994) 151:1377–1379.
   PubMed Web of Science ®Google Scholar
• SEGRAVES RT, SARAN A, SEGRAVES K, MAGUIRE E: Clomiprarnine versus placebo in the treatment of premature ejaculation: a pilot study. J. Sex Marital Ther. (1993) 19:198–200.
   PubMed Web of Science ®Google Scholar
• GIRGIS SM, EL HAGGAR S, EL HERMOUZY S: A double-blind trial of clomiprarnine in premature ejaculation. Andrologia (1982)14:364–368.
   PubMed Web of Science ®Google Scholar
• NAZARETH I, BOYNTON P, KING M: Problems with sexual function in people attending London general practitioners: cross-sectional study. Br. Med. J. (2003) 327:423.
   PubMed Web of Science ®Google Scholar
• MERCER CH, FENTON KA, JOHNSON AM et al.: Sexual function problems and help seeking behaviour in Britain: national probability sample survey. Br. Med. J (2003) 327:426–427.
   PubMed Web of Science ®Google Scholar
• LABBATE LA, CROFT HA, OLESHANSKY MA: Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation. Clin. Psychiatry (2003) 64\(Suppl. 10):11–19.
   Google Scholar
• CLAYTON AH, PRADKO JF, CROFT HA et al.: Prevalence of sexual dysfunction among newer antidepressants. Clin. Psychiatry (2002) 63:357–366.
   PubMed Web of Science ®Google Scholar
• REYNOLDS GP, ZHANG ZJ, ZHANG XB: Association of antipsychotic drug-induced weight gain with a 5-T2c receptor gene polymorphism. Lancet (2002) 359:2086–2087.
   PubMed Web of Science ®Google Scholar